Leerink Partners Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Cuts Target Price to $18
TD Cowen Maintains Stoke Therapeutics(STOK.US) With Buy Rating
BTIG Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Maintains Target Price $29
H.C. Wainwright Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Maintains Target Price $35
Stoke Therapeutics Analyst Ratings
Buy Rating Affirmed for Stoke Therapeutics Amid Solid Q2 Performance and Regulatory Progress
Stoke Therapeutics Price Target Maintained With a $22.00/Share by Needham
Buy Rating Reaffirmed for Stoke Therapeutics Amidst Clinical Progress and Strong Financial Footing
Stoke Therapeutics Analyst Ratings
Stoke Therapeutics (STOK) Receives a Buy From Wedbush
Stoke Therapeutics Analyst Ratings
Buy Rating Affirmed for Stoke Therapeutics Amid Strong Pipeline Prospects and Financial Stability
Analysts Are Bullish on Top Healthcare Stocks: Stoke Therapeutics (STOK), Oric Pharmaceuticals (ORIC)
Stoke Therapeutics Analyst Ratings
Buy Rating for Stoke Therapeutics With Adjusted Price Target Amid Regulatory and Developmental Progress
Stoke Therapeutics Analyst Ratings
Buy Rating Justified by Stoke Therapeutics' Promising Pipeline and Strategic Market Positioning
Stoke Therapeutics Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Haleon PLC (GB:HLN) and Stoke Therapeutics (STOK)
Stoke Therapeutics Analyst Ratings